Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
FREDUN Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
High and improving ROE
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Consistently pays dividend
Negative
Company's earnings are of low quality
Low dividend yield
Neutral
Moderate and stable operating margin
Reasonable Debt to Equity, and has been stable
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I).
Snapshot
See detailed analysis
FREDUN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
FREDUN Bulk, Block & Insider Trades
FREDUN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, N... Read More
Key personnel
Daulat Nariman MedhoraD
Executive Chairman of the Board, Joint Managing Director
Mr. Fredun Nariman MedhoraD
Chief Financial Officer, Managing Director, Executive Director
Vaishnavi Sahu
Compliance Officer, Company Secretary
Mr. Anshu AgarwalD
Additional Non-Executive Independent Director
Ms. Niharika AgarwalD
Non-Executive Independent Director
Ms. Sonal DesaiD
Additional Non-Executive Independent Director
Ms. Daisy Cyril DsouzaD
Additional Non-Executive Independent Director
Pooja SanghaviD
Additional Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Fredun Pharmaceuticals Ltd.?
The current share price of Fredun Pharmaceuticals Ltd. is ₹ 1,437.05 as of 09 Jan 2026.
What is the PE ratio of Fredun Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Fredun Pharmaceuticals Ltd. is 22.03 as of the latest financial data.
What is the ROE and ROCE of Fredun Pharmaceuticals Ltd.?
Fredun Pharmaceuticals Ltd. has a Return on Equity (ROE) of 21.39% and a Return on Capital Employed (ROCE) of 20.50% as per the latest financial reports.
What is the market cap of Fredun Pharmaceuticals Ltd.?
The market capitalization of Fredun Pharmaceuticals Ltd. stands at ₹ 678.58 Cr.
What is the dividend yield of Fredun Pharmaceuticals Ltd.?
The dividend yield of Fredun Pharmaceuticals Ltd. is 0.05% based on the current market price.
What is the RSI of Fredun Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Fredun Pharmaceuticals Ltd. is 32.45.
What is the FII and DII holding in Fredun Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.01% and Domestic Institutional Investors (DII) hold 1.59% of Fredun Pharmaceuticals Ltd. shares.
What sector does Fredun Pharmaceuticals Ltd. belong to?
Fredun Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Fredun Pharmaceuticals Ltd. stock?
The beta of Fredun Pharmaceuticals Ltd. stock is 0.76, indicating its volatility relative to the broader market.
